Live Breaking News & Updates on Novel Gene Therapy

Stay updated with breaking news from Novel gene therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Expansion Portion of Acclaim-1 Clinical Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer

/PRNewswire/ Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies. ....

United States , Rodney Varner , Genprex Inc , Drug Administration , Company Website , American Society Of Clinical Oncology , Safety Review Committee , Exchange Commission , Indicate Favorable Safety Profile , Novel Gene Therapy , Solid Tumor , Fast Track Designation , Chief Executive Officer , Clinical Oncology , Nanoparticle Delivery System , Private Securities Litigation Reform Act , Annual Report ,

ASGCT 2023: Abeona Therapeutics announces preclinical data from its AAV ophthalmology program

During the 26th annual meeting of the American Society of Gene & Cell Therapy, taking place through Saturday in Los Angeles, California, the company is delivering several presentations highlighting its AAV capsids and gene constructs. ....

United States , Rachel Stupay , Joseph Fogerty , Los Angeles , Brian Kevany , Paul Wille , Product Development , American Society Of Gene Cell Therapy , Abeona Therapeutics Inc , Research At Abeona , Image Credit , American Society , Cell Therapy , Vivo Production , Following Cre Mediated Recombination , Abeona Therapeutics , Novel Gene Therapy , X Linked Retinoschisis , Autosomal Dominant Optic Atrophy Caused ,

Abeona Therapeutics Announces Multiple Abstracts Accepted from its AAV Ophthalmology Program at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

CLEVELAND, April 10, 2023 Abeona Therapeutics Inc. today announced the acceptance of three abstracts at the 26th Annual Meeting of the American Society of Gene & Cell Therapy taking. | April 10, 2023 ....

Los Angeles , Brian Kevany , Paul Wille , Joseph Fogerty , Rachel Stupay , Abeona Therapeutics Inc , Head Of Research At Abeona , Ophthalmology Program , Product Development , Annual Meeting , American Society , Cell Therapy , Chief Technical Officer , Vivo Production , Following Cre Mediated Recombination , Abeona Therapeutics , Novel Gene Therapy , Senior Scientist , Autosomal Dominant Optic Atrophy Caused , Abeona Therapeutics Inc Stock Exchange , Press Release , Herapy Abeo Us00289y2063 ,

Genprex Receives Safety Review Committee Approval to Proceed to Final Cohort in Acclaim-1 Phase 1 Dose Escalation Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer

/PRNewswire/ Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies. ....

United States , Mark Berger , Exchange Commission , Genprex Inc , Drug Administration , Safety Review Committee , Increased Dose , Final Cohort , Trial Indicates Favorable Safety Profile , Novel Gene Therapy , Solid Tumor , Fast Track Designation , Chief Medical Officer , Nanoparticle Delivery System , Private Securities Litigation Reform Act , Annual Report ,

Urovant Sciences GmbH: Urovant Sciences Receives Best in Category Award for Abstract Highlighting Investigational Novel Gene Therapy, URO-902, Presented at 2022 International Continence Society Conference

Interim 12-week analysis from the ongoing Phase 2a trial of an investigational novel gene therapy product, URO-902 (plasmid human cDNA encoding maxi-K channel), receives International Continence ....

United States , Sumitovant Biopharma , Kenneth Peters , Maya Frutiger , Alana Darden Powell , Department Of Urology At Beaumont Hospital , American Urological Association , International Continence Society , Urovant Sciences Gmb , Corporate Communications , Pelvic Health Center , Urovant Sciences , Sumitovant Biopharma Ltd , Head Of Corporate Communications , Category Prize , Overactive Bladder , Continence Society , Awards List , European Time , Best Urology , Novel Gene Therapy , Female Patients , Overactive Bladder Syndrome , Urge Urinary Incontinence , Principal Investigator , Beaumont Hospital ,